The needle moves around a little bit as new contributions come in, but we are a top donor. That is sometimes first, but sometimes we bump down to second or third and then we bring in additional investments.
The international system and developing country partners are very well aware of Canada's leadership in providing access to not just vaccines, but also to health systems support, diagnostic support and access to therapies.
On therapies in particular, the development of new antivirals really is the next horizon. We want to make sure that developing countries do have equal access to them just as they do for vaccines now.